FAQs Glutathione is a powerful antioxidant that helps reduce oxidative stress
In clinical trials, patients on high-dose semaglutide (Wegovy) lost around 15% of their body weight on average over about 16 months, and those on tirzepatide lost 1522% of their weight over about 72 weeks (approximately a year and a half) [utswmed.org]
Recent data on the efficacy of tirzepatide demonstrate that incretin dual agonists have the potential to more effectively reduce HbA 1c and bodyweight than GLP-1R agonists alone [5]
This creates a systemic anti-inflammatory environment that supports tissue maintenance and repair processes
Unlike single-mechanism approaches, this combination leverages the distinct but overlapping appetite regulatory pathways of both incretin and amylin systems, creating a more comprehensive intervention for obesity and type 2 diabetes
Normal aging is associated with reduced sleep duration, lighter and more fragmented sleep, increased nocturnal awakenings, and a shift toward earlier wake times